1. Opening RemarksTrioday, a product of Cipla Ltd., falls under the category of fixed-dose combination (FDC) antiretrovirals. It is prescribed for individuals infected with HIV. The convenience of a single-tablet, once-daily regimen has made it a valuable tool in modern HIV care, merging three separate drugs into one oral dose.The arrival of FDCs l